Literature DB >> 24931895

Endoscopic biopsy samples of naïve "colitides" patients: role of basal plasmacytosis.

Vincenzo Villanacci1, Elisabetta Antonelli2, Gianpaolo Reboldi2, Marianna Salemme1, Giovanni Casella3, Gabrio Bassotti4.   

Abstract

BACKGROUND: Although it is usually not difficult to diagnose inflammatory bowel disease (IBD) on surgical resection specimens, difficulties sometimes arise in differentiating these entities from other forms of colitis on endoscopic biopsy specimens. Basal plasmacytosis is considered as an early feature of IBD colitis, but it is rare in non-IBD colitides. AIMS: We assessed the value of basal plasmacytosis as an individual variable in untreated patients with colitis. PATIENTS AND METHODS: Archival slides of patients with untreated colitis (66 IBD and 49 non-IBD) and 20 controls with complete (from the terminal ileum to the rectum) endoscopic biopsy sampling were evaluated blindly for the presence of basal plasmacytosis and a possible association with the presence of eosinophils in the same anatomical location.
RESULTS: Overall, basal plasmacytosis was present in at least one anatomical segment in 58% of cases, and it was always present in patients with IBD, whereas it was sparsely found (9%) in patients with other colitides and in controls. Basal plasmacytosis in three or more segments had more than 80% probability for a patient to be classified as IBD, with the segmental distribution being different between ulcerative colitis and Crohn's disease. Additionally, basal plasmacytosis was always accompanied by eosinophils intermingled with plasma cells in the same anatomical position.
CONCLUSION: As an individual feature, basal plasmacytosis (accompanied by eosinophils) is a strong feature suggesting IBD, particularly when present in three or more colonic segments. This fact may be useful in the evaluation of endoscopic biopsies from patients with "colitis".
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Basal plasmacytosis; Colitides; Crohn's disease; Eosinophils; Ulcerative colitis

Mesh:

Year:  2014        PMID: 24931895     DOI: 10.1016/j.crohns.2014.05.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

1.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

2.  Classification of eosinophilic disorders of the small and large intestine.

Authors:  Aoife J McCarthy; Kieran Sheahan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

3.  Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Francesco Lanzarotto; Anna Bozzola; Moris Cadei; Gabrio Bassotti
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

4.  Correlation between histological findings and endoscopic findings in patients with ulcerative colitis: Basal plasmacytosis is an important finding suggesting active inflammation.

Authors:  Takehiro Mitsuishi
Journal:  JGH Open       Date:  2018-11-11

5.  Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability.

Authors:  A Caputo; P Parente; M Cadei; M Fassan; A Rispo; G Leoncini; G Bassotti; R Del Sordo; C Metelli; M Daperno; A Armuzzi; V Villanacci
Journal:  Tech Coloproctol       Date:  2022-06-01       Impact factor: 3.699

Review 6.  Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Authors:  Ondrej Fabian; Lukas Bajer
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

7.  Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.

Authors:  Renaud Gaujoux; Elina Starosvetsky; Naama Maimon; Yehuda Chowers; Purvesh Khatri; Shai S Shen-Orr; Francesco Vallania; Haggai Bar-Yoseph; Sigal Pressman; Roni Weisshof; Idan Goren; Keren Rabinowitz; Matti Waterman; Henit Yanai; Iris Dotan; Edmond Sabo
Journal:  Gut       Date:  2018-04-04       Impact factor: 23.059

8.  Microscopic features of small bowel mucosa of patients with Crohn's disease.

Authors:  Yun Cui; Shi-Yuan Lu; Jie Xu; Yan-Shen Peng; Qi Miao; Xiao-Qing Wang; Xiao-Yu Chen; Zhi-Hua Ran
Journal:  BMC Gastroenterol       Date:  2019-12-30       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.